iShares Biotechnology ETF $IBB Position Increased by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC raised its position in iShares Biotechnology ETF (NASDAQ:IBB) by 1,871.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 619,550 shares of the financial services provider’s stock after purchasing an additional 588,124 shares during the quarter. Janney Montgomery Scott LLC owned approximately 1.25% of iShares Biotechnology ETF worth $104,562,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Dynamic Wealth Strategies LLC lifted its holdings in shares of iShares Biotechnology ETF by 16.6% during the 4th quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock valued at $71,000 after buying an additional 60 shares during the last quarter. Flagship Private Wealth LLC raised its position in iShares Biotechnology ETF by 2.0% during the fourth quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock valued at $521,000 after acquiring an additional 60 shares in the last quarter. Larson Financial Group LLC raised its position in iShares Biotechnology ETF by 2.3% during the fourth quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock valued at $458,000 after acquiring an additional 60 shares in the last quarter. Webster Bank N. A. lifted its stake in iShares Biotechnology ETF by 1.0% in the fourth quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock valued at $1,093,000 after acquiring an additional 62 shares during the last quarter. Finally, Choreo LLC lifted its stake in iShares Biotechnology ETF by 2.2% in the fourth quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock valued at $514,000 after acquiring an additional 65 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

IBB stock opened at $165.93 on Thursday. The firm has a 50 day moving average of $170.24 and a two-hundred day moving average of $170.63. iShares Biotechnology ETF has a 12 month low of $123.61 and a 12 month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were issued a $0.1218 dividend. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.